MedTrace Logo

Warfighter Head Injury Study

NCT00754169 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 314

Last updated 2017-10-06

No results posted yet for this study

Summary

This study will examine the long-term outcome of brain injuries, the effects of treatment on outcome and the effects of brain injury on people s behavior and abilities.

Men and women between 18 and 75 years of age who served in combat in the Iraq war may be eligible for this study. It will compare test results in those who sustained a traumatic penetrating or blast-related brain injury during combat with those who did not.

Participants undergo the following procedures over a 5-day period of testing that lasts about 6 hours a day:

* Medical history and physical examination.
* Blood test for genetic analysis.
* Electroencephalography (EEG) to measure the electrical activity of the brain.
* MRI or CT scans of the brain to look at the structure and blood flow of the brain.
* Functional near-infrared spectroscopy (fNIRS) to monitor blood flow in the front part of the brain blood by measuring changes in near-infrared light.
* Neuropsychological testing, including questionnaires, pen-and-paper or computerized tests, and performance of simple actions to measure brain function, language, memory and other cognitive abilities..

Conditions

  • Head Injury

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • National Institutes of Health Clinical Center (CC)

    collaborator NIH

  • Center for Neuroscience and Regenerative Medicine (CNRM)

    collaborator FED

  • National Institute of Neurological Disorders and Stroke (NINDS)

    lead NIH

Principal Investigators

  • Eric M Wassermann, M.D. · National Institute of Neurological Disorders and Stroke (NINDS)

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-09-05
Completion
2013-01-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00754169 on ClinicalTrials.gov